FDA Seeks To Encourage Onshoring With ANDA Prioritization Pilot

Faster Review Promised For Generics Manufactured And Tested In US

 
• By Dave Wallace
  
The pilot scheme will prioritize review of US-made generics (Shutterstock)

More from Regulation

More from Policy & Regulation